Metropolitan Life Insurance Company (MetLife)’s Nasdaq NDAQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-15,326
Closed -$967K 1357
2024
Q1
$967K Buy
15,326
+1,470
+11% +$85K 0.04% 338
2023
Q4
$806K Sell
13,856
-169
-1% -$8.91K 0.04% 354
2023
Q3
$681K Sell
14,025
-732
-5% -$37.1K 0.04% 374
2023
Q2
$736K Sell
14,757
-404
-3% -$21.9K 0.04% 382
2023
Q1
$829K Sell
15,161
-3,934
-21% -$227K 0.04% 359
2022
Q4
$1.17M Sell
19,095
-523
-3% -$32.6K 0.05% 331
2022
Q3
$1.11M Sell
19,618
-641
-3% -$37.7K 0.05% 333
2022
Q2
$1.03M Sell
20,259
-840
-4% -$44.5K 0.05% 360
2022
Q1
$1.25M Sell
21,099
-18,426
-47% -$1.09M 0.04% 358
2021
Q4
$2.77M Sell
39,525
-1,233
-3% -$84K 0.04% 393
2021
Q3
$2.62M Sell
40,758
-615
-1% -$38.7K 0.04% 384
2021
Q2
$2.42M Sell
41,373
-753
-2% -$41.4K 0.03% 436
2021
Q1
$2.07M Sell
42,126
-1,926
-4% -$91.5K 0.03% 501
2020
Q4
$1.95M Sell
44,052
-2,502
-5% -$106K 0.03% 487
2020
Q3
$1.9M Sell
46,554
-2,034
-4% -$86.7K 0.03% 431
2020
Q2
$1.93M Sell
48,588
-3,012
-6% -$112K 0.03% 410
2020
Q1
$1.63M Sell
51,600
-198
-0.4% -$7.01K 0.03% 459
2019
Q4
$1.85M Buy
51,798
+48
+0.1% +$1.64K 0.03% 579
2019
Q3
$1.71M Sell
51,750
-78
-0.2% -$2.59K 0.03% 572
2019
Q2
$1.66M Buy
51,828
+3,924
+8% +$120K 0.03% 609
2019
Q1
$1.4M Sell
47,904
-1,506
-3% -$42.9K 0.03% 688
2018
Q4
$1.34M Sell
49,410
-522
-1% -$14.9K 0.03% 638
2018
Q3
$1.43M Sell
49,932
-2,670
-5% -$82.2K 0.02% 721
2018
Q2
$1.6M Sell
52,602
-1,191
-2% -$35.8K 0.03% 650
2018
Q1
$1.55M Buy
53,793
+411
+0.8% +$11.1K 0.02% 689
2017
Q4
$1.37M Sell
53,382
-112,173
-68% -$2.83M 0.02% 758
2017
Q3
$4.28M Buy
165,555
+636
+0.4% +$15.8K 0.03% 666
2017
Q2
$3.93M Sell
164,919
-5,799
-3% -$133K 0.03% 700
2017
Q1
$3.95M Sell
170,718
-1,089
-0.6% -$25.3K 0.03% 707
2016
Q4
$3.84M Sell
171,807
-4,215
-2% -$93K 0.03% 713
2016
Q3
$3.96M Sell
176,022
-2,721
-2% -$62.8K 0.03% 674
2016
Q2
$3.85M Sell
178,743
-1,482
-0.8% -$31.7K 0.03% 660
2016
Q1
$3.99M Sell
180,225
-3,447
-2% -$71K 0.03% 621
2015
Q4
$3.56M Sell
183,672
-10,296
-5% -$196K 0.03% 652
2015
Q3
$3.45M Sell
193,968
-3,813
-2% -$65.4K 0.02% 672
2015
Q2
$3.22M Sell
197,781
-1,308
-0.7% -$21.9K 0.02% 765
2015
Q1
$3.38M Sell
199,089
-1,263
-0.6% -$20.6K 0.02% 696
2014
Q4
$3.2M Sell
200,352
-2,721
-1% -$40K 0.02% 749
2014
Q3
$2.87M Sell
203,073
-2,361
-1% -$33.1K 0.02% 779
2014
Q2
$2.65M Sell
205,434
-8,115
-4% -$99.2K 0.02% 867
2014
Q1
$2.63M Sell
213,549
-1,014
-0.5% -$13.1K 0.02% 844
2013
Q4
$2.85M Sell
214,563
-4,074
-2% -$49.8K 0.02% 791
2013
Q3
$2.34M Sell
218,637
-5,247
-2% -$56.1K 0.02% 846
2013
Q2
$2.45M Buy
+223,884
New +$2.28M 0.02% 776

Other funds holding NDAQ

Metropolitan Life Insurance Company (MetLife)'s NDAQ Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Nasdaq (NDAQ) in Q2 2024, closing a stake of 15,326 shares — an estimated $967K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in NDAQ in Q2 2013 and held it in 44 quarters. The position peaked at $4.28M in Q3 2017. 756 funds tracked by Wall St. Rank hold NDAQ as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Nasdaq position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 15,326 Nasdaq shares in Q2 2024, an estimated $967K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Nasdaq in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Nasdaq position peaked at $4.28M in Q3 2017.
  • 756 funds tracked by Wall St. Rank held Nasdaq as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.